Human placental chorionic somatomammotropin (hCS-A or hCS-B) and pituitary growth hormone (hGH-N) are related by structure and function. The hCS-A gene is expressed in rat pituitary tumour (GC) cells after gene transfer. Deletion of hCS-A 5'-flanking DNA reveals repressor activity upstream of nucleotide -132, and a region essential for expression in GC cells between nucleotides -94 and -61 . The sequences in this region differ from the equivalent hGH-N gene DNA by one nucleotide, and include the binding site (-92 to -65) for a pituitary-specific factor (GHF-1), required for hGH-N expression in GC cells. Exchange of hGH-N with hCS-A gene DNA in this region maintains expression in GC cells. By contrast, modification of these sequences blocks expression. These data indicate that proximal promoter sequences, equivalent to those bound by GHF-1 on the hGH-N gene, are required for hCS-A expression in GC cells.
INTRODUCTION
Human chorionic somatomammotropin (hCS), or placental lactogen, is a single-chain polypeptide hormone synthesised uniquely during pregnancy (1) . It is produced by the syncytiotrophoblast of the placenta, and is expressed by two genes, hCS-A and hCS-B, which encode identical polypeptides (2) (3) (4) (5) . The rate of secretion of hCS represents the greatest of any protein hormone in humans and yet its exact function is still unknown (1, 4) . The hCS genes are members of the human growth hormone (hGH) gene family, and are related to pituitary growth hormone (hGH-N) by structure and function (1) (2) (3) (4) . They share greater than 93% and 85% sequence similarity at the nucleotide and amino acid level, respectively (4, 6) .
In the absence of human pituitary cell lines, rat anterior pituitary tumour (GC) cells, together with gene transfer, have been used to study hGH-N gene expression, including tissue©IRLPress specificity. Initial studies revealed preferential use of the hGH-N and endogenous rat growth hormone (rGH) gene promoter in GC relative to non-pituitary cells (7) . A rat pituitary-specific factor (GHF-1) was shown to interact with two regions (-132/-107 and -92/-65) of the hGH-N and rGH gene 5'-flanking DNA (8) (9) (10) (11) . Binding of GHF-1 is a requirement for growth hormone promoter activity (8, 10) . The addition of GHF-1 to an extract prepared from non-pituitary cells is sufficient to allow hGH-N gene transcription iri vitro (11) . Clearly, expression from the hGH-N promoter in GC cells is dictated by the presence of GHF-1 , and would appear to provide a mechanism by which tissue-specific expression of the hGH-N gene is accomplished.
However, it does not explain differential expression of the hGH gene family, specifically, the structurally related hGH and hCS genes. The hCS-A gene is also expressed in GC cells (12) , and a hybrid gene containing 496 base pairs (bp) of hCS-A 5'-flanking DNA is preferentially expressed in GC cells (13) , despite being limited to the syncytiotrophoblast of the human placenta in vivo.
In this study, we assess the role of hCS-A gene 5'-flanking sequences on expression in GC cells and the appropriateness of using a heterologous system for studying tissue-specificity. These data are presented and discussed in terms of the distal and proximal GHF-1 binding regions responsible for hGH-N and rGH gene expression in GC cells.
METHODS

Materials:
The following manipulations were carried out according to published protocols (14) . Genes coding for hCS-A, hGH-N, chloramphenicol acetyl transferase (CAT) and neomycin resistance (neodX) are described elsewhere (3, 7, 15, 16) . The pCHAT vector was prepared by converting the Sal I site of pPCAT (7) to Hind III. A promoterless cat gene was generated from pCHAT by Hind III/Bql II digestion, blunting with Klenow and ligation in the presence of Hind III linkers. The 5'-flanking sequences (-496/+2) of the hCS-A or hGH-N genes were excised in a Hind Ill/Bam HI fragment; the Eco R1 and Bam H1 sites are at nucleotide positions -496 and +2, respectively. These sequences were ligated upstream of the cat gene in pCHAT, opened with a Hind III/Bgl II digest, to form -496hGH-Np.cat or -496hCS-Ap.cat (Fig. 1) . These hybrids were cut with Nsi I, at nucleotide position -84, and Hind III to generate fragments containing -496/-84 of the hCS-A or hGH-N genes. These regions were exchanged to form hybrid hCS/hGH genes -496/-84hCS-A.-83hGH-Np.cat or -496/-84hGH-N.-83hCSp.cat (Fig. 1) . Deletions (-n) of the hCS-A gene were obtained by cutting -4 96hCS-Ap.cat with Hind III and treating with Bal 31. Following ligation in the presence of Xho I linkers, the hCS-A gene deletions, together with the cat gene, were isolated by Xho I/Bam H1 digestion and ligated into pPCAT (7) cut with Sal I/Bam H1 . The end points of the 5'-flanking deletions were determined by dideoxy sequencing of the double-stranded plasmid DNA using a pBR322 Sal I site counter-clockwise primer (New England Biolabs) (17) . Internal deletions were prepared by opening -496hCS-Ap.cat or an equivalent hGH-N hybrid at -84 with Nsi I, blunting with Klenow and religation; insertional mutation of the -84 site was done by introducing a Bam HI decanucleotide linker into the blunted -84 site before ligation. Cell Culture and Gene Transfer:
Monolayer rat anterior pituitary tumour (GC) cells were grown on 100 mm dishes in Dulbecco's modified Eagle's medium supplemented with 5% foetal calf serum and 5% calf serum. GC cells were stably and transiently transfected by calcium phosphate/DNA precipitation as described previously (12, 13, 18) . For analysis, stable cell lines and cells for transient transfection were plated at an initial density of 3 x 10^ per 100 mm dish. Stably transfected cells were harvested 48 hours after plating. Transient transfections were carried out 18-24 hours after plating and the cells were harvested 40-48 hours later. CAT Assays:
Cells were rinsed with phosphate buffered saline (PBS) and harvested using 1 mM EDTA in PBS. Following centrifugation, the cells in the pellet were lysed in Tris-HCl/Triton X-100 (0.1 M Tris-HCl pH 7.8, 0.1% (v/v) Triton X-100) for 10 min on ice. Insoluble material was removed by centrif ugation. A two-phase fluor diffusion assay was used to determine CAT activity (19) . Briefly, cell extract (0.1 to 0.3 mg ) is added to a 7 ml scintillation vial with sufficient Tris-HCl/Triton to give a total volume of 0.2 ml. The solution is heated to 70 °C for 10 rnin, cooled to room temperature, and a reaction mix (75 ul) , containing 2 ul 3n-acetyl CoA (specific activity about 4 Ci/mmol; 0.5 uCi per assay), 50 pi of 5 mM chloramphenicol (in water), 7.5 ul of 1 M Tris-HCl pH 7.8 and 15.5 ul of water, added. The reaction mixture is carefully overlaid with 3 ml organic phase scintillation cocktail. After 30 min the samples are cycle counted for at least 1 min for 3 to 5 hours. Quantitative values for CAT activity are determined by regression analysis to give counts per minute, per minute, per mg (cpm/min/mg) of protein cell extract. Results obtained from separate experiments using stable tranfection or from separate experiments using transient transfection are comparable.
RESULTS
A series of 5'-flanking deletions was constructed to identify and localise regions important for expression of the hCS-A gene in GC cells. Truncated regions of the hCS-A 5'-flanking sequences, including the promoter, were ligated upstream of the chloramphenicol acetyl transferase (cat) gene, and were stably introduced into GC cells. CAT activity from pools (greater than 50 clones) of these cells was assessed, and the results are shown in Fig. 2 . Hybrid genes containing deletions from -315 to -152 were expressed at comparable levels. However, the -132hCS-Ap.cat gene and -124hCS-Ap.cat gene displayed about a 3 and 7-fold increase in CAT activity, respectively. These data suggest the presence of an element which is contained, at least in part, between nucleotide positions -152 and -132 that suppresses hCS-A expression in GC cells. Further deletion from -124 to -94 results in a decrease in gene expression which, with further deletion, declines to levels of CAT activity seen with untransfected cells (Fig. 2) . These data indicate that sequences within the region -94 to -61 are required for hCS-A gene expression in GC cells. To determine whether the same factor(s) could be used by hCS-A and hGH-N genes for expression in GC cells, their gene sequences within the GHF-1 binding domain were exchanged; integrity of this domain is a requirement for hGH-N promoter activity in GC cells (10) . A convenient Nsi I site at nucleotide position -84 of the hCS-A and hGH-N genes was used to construct the chimaeric genes (Fig. 1) . The hGH-N gene sequences upstream of the -84 site were ligated to sequences downstream of this position in the hCS-A gene to form -496/-84hGH-N.-83hCS-Ap.cat. The hybrid -496/-84hCS-A.-83hGH-Np.cat gene was made in a similar manner (Fig. 1) . Note, the exchange will also include the complete distal GHF-1 binding site. These hybrid genes were used to transiently transfect GC cells and CAT activity was assessed. (Table 1 ). This suggests that proximal promoter sequences in the region of nucleotide position -84 are a requirement for expression of hCS-A as well as hGH-N in GC cells. 
DISCUSSION
In this study we have shown that sequences in the first 94 bp of the hCS-A 5'-flanking DNA will support expression in GC cells (Fig. 2) . This would exclude sequences corresponding to the distal GHF-1 binding site on the hGH-N gene (Fig. 3) . Deletion of the hCS-A 5'-flanking DNA into the sequences corresponding to the proximal GHF-1 site on the hGH-N gene (Fig. 3 ) results in the loss of gene expression (Fig. 2) . Further, modification of the proximal GHF-1 binding domain, without deletion of adjacent sequences, blocks hCS-A (and hGH-N) promoter activity (Table 1) . Our data also indicate that the hCS-A promoter is active in GC cells through binding of GHF-1 . Sequences of the proximal GHF-1 binding site in hGH-N can be exchanged with the equivalent sequences from the hCS-A gene and expression in GC cells is still observed. Since GHF-1 binding is an absolute requirement for hGH-N promoter activity (10, 11) , the hCS-A sequences must be able to support GHF-1 binding. These data are predicted by a sequence comparison shown in Fig. 3 ; the hGH-N and hCS-A gene sequences in (Table 1) . Thus, it is probable that the modifications made to the hCS-A, as well as the hGH-N, gene (i) interfere with GHF-1 binding in the proximal domain and (ii) indicate that the distal GHF-1 binding region or sequences are not used in the absence, and possibly presence, of binding to the proximal site.
This latter point contrasts with the situation observed with the rGH gene in GC cells and, consequently, is unexpected. Binding of GHF-1 to the distal (or GC2) site in the rGH gene is required for promoter activity in GC cells (8, 9) . The distal GHF-1 binding domain is strikingly similar in the rGH and human genes (Fig.  3) . Indeed, the proximal site used by the hGH-N and hCS-A genes differs significantly from that (GC1) in the rGH gene (see lower case letters in Fig. 3) . Thus, it might be expected that in the absence of binding to the proximal site, that the distal GHF-1 site within the hGH-N and hCS-A genes, and used by the rGH gene, would be functional. However, since the proximal GHF-1 site does play a dominant role in hGH-N or hCS-A gene expression in GC cells, this could imply that GHF-1 induced rGH gene expression is accomplished in a different manner. At present, the possibility that GHF-1 allows hGH-N and hCS-A gene activity because they contain sequences related to those that confer tissue-specificity on the rGH gene promoter, cannot be excluded. However, given the sequence similarity between the rat and human genes, it is likely that "human GHF-1" will play a role in expression of both hGH-N and hCS-A, but that additional interactions with other factors and/or elements will be required to distinguish the hGH and hCS genes.
The results of this study also suggest the presence of repressor activity in the hCS-A gene sequences upstream of nucleotide -132; deletion of sequences from nucleotide position -152 to -132 results in an increase in hybrid hCS-A/cat gene expression (Fig. 2 ). Similar elements are described for a number of genes, and a combination of repressor and stimulator elements clearly play a role in gene regulation (22) (23) (24) (25) (26) (27) , including the hGH-N gene (7, 27) . Repressor activity in the hGH-N gene was localised to the region -308/-235 (27) . Further characterisation of the repressor region in the hCS-A gene, its relationship to sequences identified in the hGH-N gene and their possible role in cell-specificity are in progress.
In conclusion, GC cells still remain an effective model for studying potential regulators of hGH and hCS gene expression. However, the mechanism for differential expression of these genes, and perhaps genes in other systems, could require identification of tissue-specific factors in a homologous system, not only by gene and tissue, but also by species.
